Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kent W Mouw

Showing results (31-40 of 121) with videos related to

Pageof 13
Sort By:
International Journal of Radiation Oncology, Biology, Physics|June 26, 2020
Doublecortin Expression in Prostate Adenocarcinoma and Neuroendocrine TumorsShervin Tabrizi, Mohammed Alshalalfa, Brandon A Mahal, et al.
Annals of Palliative Medicine|January 9, 2018
Impact of a dedicated palliative radiation oncology service on the use of single fraction and hypofractionated radiation therapy among patients with bone metastasesSonia Skamene, Isha Agarwal, Maggie Makar, et al.
Current Urology Reports|October 9, 2024
Impact of DNA Repair Deficiency in the Evolving Treatment Landscape of Bladder CancerVincent D D'Andrea, Christopher J Magnani, John Ernandez, et al.
Brachytherapy|November 1, 2020
Utilization of multimodality therapy with primary radical prostatectomy versus radiation therapy for Gleason 8-10 prostate cancerMartin T King, Vinayak Muralidhar, David D Yang, et al.
Scientific Reports|November 10, 2024
Assessing expression patterns of PTGR1, a potential biomarker for acylfulven sensitivity in urothelial carcinomaDag Rune Stormoen, Signe Lehn, Kent W Mouw, et al.
International Journal of Radiation Oncology, Biology, Physics|October 29, 2021
Radiation Dose to the Intraprostatic Urethra Correlates Strongly With Urinary Toxicity After Prostate Stereotactic Body Radiation Therapy: A Combined Analysis of 23 Prospective Clinical TrialsJonathan E Leeman, Yu-Hui Chen, Paul Catalano, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 25, 2021
Second malignancy probabilities in prostate cancer patients treated with SBRT and other contemporary radiation techniquesEdward Christopher Dee, Vinayak Muralidhar, Martin T King, et al.
Nature Genetics|April 26, 2016
Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumorsJaegil Kim, Kent W Mouw, Paz Polak, et al.
American Journal of Clinical Oncology|October 19, 2017
Travel Distance as a Barrier to Receipt of Adjuvant Radiation Therapy After Radical ProstatectomyDavid D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
Journal of Molecular Biology|September 28, 2010
Sin resolvase catalytic activity and oligomerization state are tightly coupledKent W Mouw, Andrew M Steiner, Rodolfo Ghirlando, et al.
Pageof 13

Showing results (31-40 of 121) with videos related to

Sort By:
Pageof 13
International Journal of Radiation Oncology, Biology, Physics|June 26, 2020
Doublecortin Expression in Prostate Adenocarcinoma and Neuroendocrine TumorsShervin Tabrizi, Mohammed Alshalalfa, Brandon A Mahal, et al.
Annals of Palliative Medicine|January 9, 2018
Impact of a dedicated palliative radiation oncology service on the use of single fraction and hypofractionated radiation therapy among patients with bone metastasesSonia Skamene, Isha Agarwal, Maggie Makar, et al.
Current Urology Reports|October 9, 2024
Impact of DNA Repair Deficiency in the Evolving Treatment Landscape of Bladder CancerVincent D D'Andrea, Christopher J Magnani, John Ernandez, et al.
Brachytherapy|November 1, 2020
Utilization of multimodality therapy with primary radical prostatectomy versus radiation therapy for Gleason 8-10 prostate cancerMartin T King, Vinayak Muralidhar, David D Yang, et al.
Scientific Reports|November 10, 2024
Assessing expression patterns of PTGR1, a potential biomarker for acylfulven sensitivity in urothelial carcinomaDag Rune Stormoen, Signe Lehn, Kent W Mouw, et al.
International Journal of Radiation Oncology, Biology, Physics|October 29, 2021
Radiation Dose to the Intraprostatic Urethra Correlates Strongly With Urinary Toxicity After Prostate Stereotactic Body Radiation Therapy: A Combined Analysis of 23 Prospective Clinical TrialsJonathan E Leeman, Yu-Hui Chen, Paul Catalano, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 25, 2021
Second malignancy probabilities in prostate cancer patients treated with SBRT and other contemporary radiation techniquesEdward Christopher Dee, Vinayak Muralidhar, Martin T King, et al.
Nature Genetics|April 26, 2016
Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumorsJaegil Kim, Kent W Mouw, Paz Polak, et al.
American Journal of Clinical Oncology|October 19, 2017
Travel Distance as a Barrier to Receipt of Adjuvant Radiation Therapy After Radical ProstatectomyDavid D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
Journal of Molecular Biology|September 28, 2010
Sin resolvase catalytic activity and oligomerization state are tightly coupledKent W Mouw, Andrew M Steiner, Rodolfo Ghirlando, et al.
Pageof 13